In patients with reversible perfusion defects, no measured parameter differed significantly between metoprolol plus glucagon and metoprolol alone.
In plain wordsIn patients with reversible perfusion defects, adding glucagon to metoprolol did not significantly change the measured stress-test parameters.
- Peptide
- Glucagon
- Outcome
- No significant changeStress-test parameters
- Study
n = 22
- Comparator
- Metoprolol alone
- Outcome group
- Heart function · Cardiovascular
- Studied dose
- 1 mg · intravenousAs given in this study (human).
Source sentences
No significant differences were found in any parameter between metoprolol and metoprolol-glucagon.
3 context sentences(design, population, supporting numbers)
Randomized, double-blind, placebo-controlled trial.
Twenty-two patients with known reversible perfusion defects.
Before dobutamine was begun, no therapy was given during the first visit, and patients were randomized on subsequent visits to receive metoprolol or metoprolol plus glucagon 1 mg.